Dianthus Therapeutics
DNTH
DNTH
51 hedge funds and large institutions have $162M invested in Dianthus Therapeutics in 2018 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 13 increasing their positions, 5 reducing their positions, and 16 closing their positions.
Holders
51
Holders Change
+3
Holders Change %
+6.25%
% of All Funds
1.17%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
19
Increased
13
Reduced
5
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CC
1
Casdin Capital
New York
|
$27M |
| 2 |
OM
2
Opaleye Management
Boston,
Massachusetts
|
$8.71M |
| 3 |
3
Fidelity International
Hamilton,
Bermuda
|
$11.5M |
| 4 |
4
BlackRock
New York
|
$2.06M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$1.74M |
Top Sellers
| 1 |
1
Millennium Management
New York
|
$0 |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$0 |
| 3 |
3
Goldman Sachs
New York
|
$0 |
| 4 |
4
Alkeon Capital Management
New York
|
$0 |
| 5 |
5
Norges Bank
Oslo,
Norway
|
$86K |
